May 15, 2020 / 7:57 PM / 21 days ago

BRIEF-FDA Approves First Drug For Fourth-Line Treatment Of Advanced Gastrointestinal Stromal Tumors

May 15 (Reuters) - FDA:

* FDA APPROVES FIRST DRUG FOR FOURTH-LINE TREATMENT OF ADVANCED GASTROINTESTINAL STROMAL TUMORS

* FDA - APPROVED QINLOCK TABLETS AS FIRST NEW DRUG SPECIFICALLY APPROVED AS FOURTH-LINE TREATMENT FOR ADVANCED GASTROINTESTINAL STROMAL TUMOR

* FDA - GRANTED APPROVAL OF QINLOCK TO DECIPHERA PHARMACEUTICALS

* FDA - APPROVED DECIPHERA PHARMACEUTICALS’ QINLOCK THREE MONTHS AHEAD OF SCHEDULE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below